Phathom Pharmaceuticals PHAT Balance Sheet (2018-2026)

NASDAQ PHAT
$5.36 +0.03 (+0.47%)
As of: Nov 10, 2026 · 1:26 PM EST
Reported Financials

Phathom Pharmaceuticals Quarterly Balance Sheet

Periods 33 quarters
Latest Sep 2026

Phathom Pharmaceuticals reported total assets of $345.02M and total liabilities of $692.66M for the quarter ended Sep 2026, up 43.6% year over year. This balance sheet covers 33 quarters of results from Sep 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
183.42M138.60M207.90M197.34M155.89M130.08M249.38M216.54M384.26M325.10M279.10M337.54M300.13M215.18M152.43M138.02M132.83M183.77M185.34M187.42M
Cash & Current Investments
183.42M138.60M207.90M197.34M155.89M130.08M249.38M216.54M384.26M325.10M279.10M337.54M300.13M215.18M152.43M138.02M132.83M183.77M185.34M187.42M
Receivables - NetNet Receivables
1.30M3.88M10.88M21.05M35.65M36.36M51.26M55.79M76.11M80.72M97.42M107.60M
Receivables - OtherOther Receivables
Receivables
1.30M3.88M10.88M21.05M35.65M36.36M51.26M55.79M76.11M80.72M97.42M107.60M
Raw Materials
0.11M0.11M0.56M0.64M1.30M2.02M1.73M1.44M0.99M1.01M4.06M5.03M6.22M6.46M
Finished Goods
0.65M0.82M0.88M1.09M1.48M1.73M2.44M2.60M1.46M1.48M1.50M1.17M
Inventory
0.11M0.11M1.21M1.46M2.18M3.11M3.21M3.17M3.43M3.61M5.52M6.51M7.71M7.63M
Prepaid Assets
3.27M7.65M1.87M0.98M5.13M10.27M8.76M12.94M13.19M12.75M15.50M14.98M20.87M13.06M14.62M13.23M15.35M8.44M8.30M8.22M
Current Assets
186.53M145.74M209.26M197.81M160.51M139.84M257.72M226.73M397.43M340.31M304.79M373.82M360.13M264.90M218.88M207.78M228.97M276.57M295.92M308.01M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.65M0.71M0.88M0.83M1.21M1.28M1.16M1.98M2.15M1.96M1.81M1.66M1.48M1.35M1.24M1.16M1.06M1.02M0.97M0.94M
Other Non-Current Assets
0.34M0.81M0.81M0.81M0.80M0.80M4.28M6.61M4.56M4.56M4.56M4.55M4.56M4.56M4.56M4.56M5.78M5.95M5.95M6.43M
Non-Current Assets
2.91M3.31M4.25M4.12M4.30M4.17M7.32M10.27M16.41M16.19M14.59M13.22M18.18M29.31M31.35M32.51M30.18M28.55M31.16M37.01M
Assets
189.43M149.05M213.50M201.93M164.81M144.01M265.04M236.99M413.84M356.50M319.38M387.04M378.32M294.21M250.22M240.29M259.15M305.12M327.08M345.02M
Liabilities
Current Liabilities
Accounts Payables
5.15M2.86M5.76M7.14M10.00M4.81M4.17M5.79M12.60M8.40M7.66M7.13M10.51M11.62M4.01M1.08M4.98M6.37M5.36M11.11M
Notes Payables
Payables
5.15M2.86M5.76M7.14M10.00M4.81M4.17M5.79M12.60M8.40M7.66M7.13M10.51M11.62M4.01M1.08M4.98M6.37M5.36M11.11M
Accumulated Expenses
11.88M8.05M14.35M13.98M15.53M8.93M16.38M14.41M18.34M17.85M28.72M37.28M54.94M44.83M66.05M67.11M91.66M84.99M110.46M122.60M
Other Accumulated Expenses
0.04M0.06M0.04M0.03M0.15M0.06M0.02M0.02M0.12M3.35M0.73M1.79M3.04M2.81M4.87M4.79M7.50M5.61M6.93M6.63M
Short term Debt
Current Deferred Revenue
0.28M2.39M7.11M16.48M9.91M20.19M19.78M17.27M21.53M24.34M27.25M33.02M37.28M40.52M
Total Current Liabilities
18.92M11.39M21.08M22.88M26.24M14.44M21.55M23.98M38.78M43.46M47.01M65.29M85.73M74.03M91.82M93.12M132.04M125.04M153.78M174.90M
Non-Current Liabilities
Non-Current Debt
89.67M91.04M92.43M93.88M95.26M96.64M97.81M99.26M137.84M149.02M174.42M175.73M201.41M203.25M205.14M207.09M209.09M163.68M164.59M165.54M
Non-Current Deferred Revenue
109.53M119.80M123.40M299.82M302.53M321.19M322.39M333.26M343.81M347.00M348.98M350.12M347.90M347.63M346.97M
Operating Leases
1.18M1.08M1.39M1.25M1.10M0.95M0.79M0.63M0.46M0.29M0.13M0.59M2.12M2.07M1.96M1.86M1.74M
Other Non-Current Liabilities
7.50M7.50M7.50M7.50M7.50M7.50M7.50M7.50M9.70M9.70M10.45M10.75M11.50M11.50M11.50M11.50M4.00M3.50M3.50M3.50M
Total Non-Current Liabilities
109.78M103.51M213.00M220.85M232.12M226.71M239.94M247.27M476.90M495.30M542.76M563.41M620.40M621.08M644.55M651.32M693.32M638.58M667.85M689.16M
Total Liabilities
117.28M111.01M220.50M228.35M239.62M234.21M247.44M254.77M486.60M505.00M553.21M574.16M631.90M632.58M656.05M662.82M697.32M642.08M671.35M692.66M
Shareholder's Equity
Total Debt
89.67M91.04M92.43M93.88M95.26M96.64M97.81M99.26M137.84M149.02M174.42M175.73M201.41M203.25M205.14M207.09M209.09M163.68M164.59M165.54M
Common Equity
72.16M38.04M-7.00M-26.42M-74.81M-90.20M17.60M-17.77M-72.76M-148.50M-233.83M-187.11M-253.58M-338.38M-405.83M-422.53M-438.17M-336.96M-344.27M-347.64M
Liabilities and Shareholders Equity
189.43M149.05M213.50M201.93M164.81M144.01M265.04M236.99M413.84M356.50M319.38M387.04M378.32M294.21M250.22M240.29M259.15M305.12M327.08M345.02M
Retained Earnings
-529.37M-570.04M-620.96M-672.05M-727.09M-764.91M-805.87M-849.12M-928.69M-1,011.54M-1,102.98M-1,188.56M-1,263.01M-1,357.33M-1,433.14M-1,463.11M-1,484.26M-1,514.63M-1,532.21M-1,546.11M
Treasury Shares
1.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.0019.00

Phathom Pharmaceuticals Balance Sheet API

Pull Phathom Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PHAT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY